WHO ICTRP trial
Dexmedetomidine an adjuvant to ropivacaine in femoral nerve block: a randomized…
ChiCTR-IPR-15006646 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-IPR-15006646 |
|---|---|
| Public title | Dexmedetomidine an adjuvant to ropivacaine in femoral nerve block: a randomized double blind prospective study |
| Scientific title | Dexmedetomidine an adjuvant to ropivacaine in femoral nerve block: a randomized double blind prospective study |
| Primary sponsor | Deparment of Anesthesiology, Peking university third hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | Post-market |
| Countries | China |
| Conditions | Anterior cruciate ligament rupture |
| Interventions | D?:add dexmedetomidine 100ug;Control:ropivacaine |
| Registration date | Jun 24, 2015 |
| Target size | D?:40;Control:40 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: